Deadline: 25-Jul-25
Pfizer and the L’Association Marocaine de Recherche et de Formation en Oncologie Médicale (AMFROM) are collaborating to offer a new grant opportunity seeking proposals for quality improvement initiatives to improve the quality of care and to help build capacity to address the needs of breast cancer (BC) patients in French speaking Sub-Saharan Africa.
Area of Interests
- Primary Area of Interest
- Oncology – Breast Cancer
- Specific Area of Interest for this RFP
- It is not the intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.
- It is the intent to support projects that focus on:
- Developing and implementing culturally appropriate provider and patient education, including addressing stigmas associated with breast cancer.
- Optimization of patient management and referral pathways to promote initiation, adherence, and completion of breast cancer care.
- Utilization of technology to improve access to care and communication with providers, including telehealth and mobile applications.
- Developing and/or disseminating practical screening programs tailored for rural and remote settings.
- Improving access to, and utilization of supportive care, and palliative care.
- Developing and training the non-oncology workforce (e.g. general practitioners, community health workers, etc.) to address the needs of breast cancer patients.
- Approaches to establish and sustain multi-disciplinary teams to support breast cancer patients.
- Developing local expertise in breast cancer management to enhance long-term capacity and self-sufficiency.
- Strengthening post-treatment follow-up and survivorship programs to improve long-term patient outcomes.
Funding Information
- Individual projects requesting up to $50K will be considered. The estimated total available budget related to this RFP is $150K.
Duration
- Maximum project length is 2 years.
Geographic Scope
- Mali, Senegal, DRC, Togo, Benin
Target Audience
- Healthcare professionals working on the diagnosis and management of breast cancer (e.g., Oncologists, specialty nurses, pathologists, radiologists, patient educators, etc.)
Eligibility Criteria
- The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
- The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator).
- The Project Lead/PI must be an employee or contractor of the requesting organization.
For more information, visit Pfizer.
